Company / Revenue
GYRE THERAPEUTICS, INC. Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$116.6M
FY2025
5-year range
$7.3M / $116.6M
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#103 of 155
Health Care
What the data says
At $117M, GYRE THERAPEUTICS, INC.'s revenue ranks #103 of 155 in the Health Care sector. Improved from $102M to $117M over the past 2 years.
Based on SEC 10-K filings.
$117M in FY2025 with a 5-year CAGR of +41.0%.
Improved from $102M to $117M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- +41.0%
- 10-Year CAGR
- -
Sector benchmark
#103 of 155 in Health CareTop 66% of 155This company $116.6M Sector average $4.5B
▼
-97.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +41.0%, indicating consistent growth.
- In FY2025, revenue increased 10.2% year-over-year.
- Ranks #103 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $116.6M | +10.2% |
| FY2024 | $105.8M | +3.4% |
| FY2023 | $102.3M | +0.0% |
| FY2022 | $102.3M | +1294.0% |
| FY2021 | $7.3M | -65.0% |
| FY2020 | $20.9M | - |
| FY2019 | - | - |
| FY2018 | $1.0M | +0.0% |
| FY2017 | $1.0M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026